国际眼科纵览
• 综述 • 上一篇 下一篇
廖凯 曾庆延
收稿日期:
出版日期:
发布日期:
通讯作者:
LIAO Kai, ZENG Qing-yan
Received:
Online:
Published:
Contact:
摘要:
角膜胶原交联术(corneal collagen cross linking,CXL)是目前治疗角膜扩张性疾病的有效手段,经典去上皮技术长期效果肯定,但手术时间长,部分患者存在并发症。为提高安全性,CXL技术在不断改良,包括经上皮胶原交联、强紫外线光快速交联等。但这些改良CXL长期有效性尚存争议。去上皮胶原交联仍是目前最有效的胶原交联术式,目前报道的经上皮胶原交联及快速胶原交联的效果良好,但远期效果有待进一步随访研究。
Abstract:
Corneal collagen cross linking has become the most effective treatment for corneal dilated diseases. The effect of tranditional epithelium-off corneal cross linking is well-known, but it take too much time on surgical time, and some patients showed side effects after surgery. In order to improve the surgical safety, some improved surgical techniques have been developed, include transepithelial corneal cross linking and accelerated corneal cross linking, but there’s a lot of debate about the validity of these. The epithelium-off corneal cross linking is the most effective surgical method for now, the efficacy of epithelium-on and accelerated corneal cross linking in short term was well, but it still needs more long-term results to verify the effectiveness for treating keratoconus.
廖凯 曾庆延. 角膜胶原交联术的远期效果[J]. 国际眼科纵览, doi: 10.3760/ cma.j.issn.1673-5803.2016.04.008.
LIAO Kai, ZENG Qing-yan. Long-term efficacy of corneal cross linking[J]. International Review of Ophthalmology, doi: 10.3760/ cma.j.issn.1673-5803.2016.04.008.
0 / / 推荐
导出引用管理器 EndNote|Ris|BibTeX
链接本文: http://www.j-bio.net/CN/10.3760/ cma.j.issn.1673-5803.2016.04.008
http://www.j-bio.net/CN/Y2016/V40/I4/252